skip to Main Content
SentreHEART International
  • Home
  • For Patients
  • For Healthcare Professionals
  • About Us
    • Company
    • Leadership
    • Careers
    • Medical Advisory Board
  • Contact

Press Room

Home » Press Room

SentreHEART Announces First Clinical Use of the Eclipse Surgical Left Atrial Appendage Closure Device

  • October 11, 2016
  • Press Releases

Redwood City, CA – October 11, 2016 – SentreHEART Inc., an innovator of solutions for left atrial appendage closure (LAAC), announced today it has treated the first patients using the EclipseTM Surgical Device, which is approved and CE Marked in Europe. Krzysztof…

Read More→

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

  • September 27, 2016
  • Press Releases

Redwood City, CA – Sept. 27, 2016 – SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), today announced it has closed a $35 million Series D round of financing. Deerfield Management Company, a…

Read More→

SentreHEART Receives 510k Approval for the LARIAT XT Suture Delivery Device

  • May 5, 2016
  • Press Releases

REDWOOD CITY, Calif. – May 05, 2016 – SentreHEART, Inc. announced that it has received 510k approval for the LARIAT® XT, the latest in a family of soft tissue closure devices, designed to offer remote suture delivery for immediate, complete closure, with…

Read More→

SentreHEART to Present on First of Its Kind Treatment for Atrial Fibrillation at LAA Conference in Frankfurt, Germany

  • November 13, 2015
  • Press Releases

FRANKFURT, Germany – November 13, 2015 – SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device will be presenting recent data on the use and benefits of the LARIAT as a therapeutic and prophylactic solution for patients with atrial…

Read More→

SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device

  • October 8, 2015
  • Press Releases

REDWOOD CITY, Calif. – October 08, 2015 – SentreHEART, Inc. announced that it has received CE Mark approval for the LARIAT Surgical Left Atrial Appendage (LAA) Suture Delivery Device. The LARIAT Surgical LAA device is a new, intuitive, suture-based solution for…

Read More→

SentreHEART Elects Medical Device Industry Veteran Richard Ferrari to Board of Directors

  • August 24, 2015
  • Press Releases

Redwood City, CA – SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced the election of medical device industry veteran Richard Ferrari to its Board of Directors. Mr. Ferrari is currently the Managing Director and Co-­‐Founder of…

Read More→

SentreHEART Receives FDA Approval for the aMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial Appendage as Adjunctive Treatment for Atrial Fibrillation

  • June 25, 2015
  • Press Releases

REDWOOD CITY, Calif. – June 25, 2015 – SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin…

Read More→

SentreHEART Secures $26 Million in Series C Financing for Commercialization

  • May 29, 2012
  • Press Releases

Proceeds to support commercialization activities of its FDA-cleared and CE-marked LARIAT® Suture Delivery Device Redwood City, CA – June 4, 2012 – SentreHEART, Inc., a privately-held medical device company announced that it has recently completed a $26 million Series C financing…

Read More→
  • Company
  • Leadership
  • Careers
  • Medical Advisory Board
  • Press Room
  • Contact
International Media Kit

Products and therapies on the international website may not be approved or cleared in the US or may be limited to investigational use only.

© 2020 SentreHEART, Inc. All rights reserved.
SentreHEART, LARIAT, EndoCATH, FindrWIRZ, SofTIP, TenSURE, and SureCUT are registered trademarks or trademarks of SentreHEART, Inc. All SentreHEART devices have received CE Mark certification.

  • For Patients
  • For Healthcare Professionals
  • Terms of Use
  • Privacy
  • CA Privacy
  • Cookies
  • Press Room
  • Contact
By clicking "Okay" or continuing to use our site, you acknowledge that you accept our Website's Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible website experience. Learn more here.Okay!